Safety and Considerations of the COVID-19 Vaccine Massive Deployment.
作者信息
Li Junwei, Song Mingyue, Guo Deyin, Yi Yongxiang
机构信息
Department of Infectious Diseases, The Second Hospital of Nanjing, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210003, China.
Public Health and Therapy Center of Nanjing, Nanjing, 211113, China.
出版信息
Virol Sin. 2021 Oct;36(5):1097-1103. doi: 10.1007/s12250-021-00408-5. Epub 2021 Jun 1.
Abstract
摘要
相似文献
1
Safety and Considerations of the COVID-19 Vaccine Massive Deployment.新冠疫苗大规模接种的安全性及注意事项
Virol Sin. 2021 Oct;36(5):1097-1103. doi: 10.1007/s12250-021-00408-5. Epub 2021 Jun 1.
2
Current and future nanoparticle vaccines for COVID-19.用于 COVID-19 的当前和未来纳米颗粒疫苗。
EBioMedicine. 2021 Dec;74:103699. doi: 10.1016/j.ebiom.2021.103699. Epub 2021 Nov 19.
3
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告：评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
4
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
5
Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.关于 COVID-19 疫苗的早期批准和使用的伦理和科学考虑。
Ann Intern Med. 2021 Feb;174(2):258-260. doi: 10.7326/M20-7357. Epub 2020 Nov 20.
6
Application of Traditional Vaccine Development Strategies to SARS-CoV-2.传统疫苗开发策略在 SARS-CoV-2 中的应用。
mSystems. 2023 Apr 27;8(2):e0092722. doi: 10.1128/msystems.00927-22. Epub 2023 Mar 2.
7
Trajectory of SARS-CoV-2 anti-S IgG levels following transfusion and a third dose of BNT162b2 vaccine in a patient with massive postoperative bleeding: A case report.新冠病毒 IgG 抗体水平在大量术后出血患者输注后和第三剂 BNT162b2 疫苗接种后的变化轨迹：病例报告。
Int J Infect Dis. 2022 May;118:138-140. doi: 10.1016/j.ijid.2022.02.042. Epub 2022 Feb 24.
8
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.一种基于重组串联重复二聚体 RBD 的蛋白亚单位疫苗（ZF2001）在成年人中的安全性和免疫原性：两项随机、双盲、安慰剂对照、1 期和 2 期临床试验。
Lancet Infect Dis. 2021 Aug;21(8):1107-1119. doi: 10.1016/S1473-3099(21)00127-4. Epub 2021 Mar 24.
9
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis.新型冠状病毒2疫苗在真实世界研究中的有效性和安全性：一项系统评价与荟萃分析
Infect Dis Poverty. 2021 Nov 14;10(1):132. doi: 10.1186/s40249-021-00915-3.
10
mRNA vaccines for COVID-19: what, why and how.用于新冠肺炎的信使核糖核酸疫苗：是什么、为何以及如何发挥作用
Int J Biol Sci. 2021 Apr 10;17(6):1446-1460. doi: 10.7150/ijbs.59233. eCollection 2021.
引用本文的文献
1
Advances in Nucleic Acid Universal Influenza Vaccines.核酸通用流感疫苗的进展
Vaccines (Basel). 2024 Jun 17;12(6):664. doi: 10.3390/vaccines12060664.
2
Attitudes to Being Vaccinated Against COVID-19: A Survey of People With Epilepsy in China.对新冠病毒疫苗接种的态度：一项针对中国癫痫患者的调查
Front Neurol. 2021 Oct 5;12:743110. doi: 10.3389/fneur.2021.743110. eCollection 2021.
本文引用的文献
1
Unsupervised clustering analysis of SARS-Cov-2 population structure reveals six major subtypes at early stage across the world.对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）种群结构的无监督聚类分析揭示了全球早期阶段的六种主要亚型。
bioRxiv. 2021 Nov 24:2020.09.04.283358. doi: 10.1101/2020.09.04.283358.
2
Assessment of US Healthcare Personnel Attitudes Towards Coronavirus Disease 2019 (COVID-19) Vaccination in a Large University Healthcare System.美国大型大学医疗体系中医疗人员对 2019 年冠状病毒病（COVID-19）疫苗接种态度的评估。
Clin Infect Dis. 2021 Nov 16;73(10):1776-1783. doi: 10.1093/cid/ciab054.
3
Are COVID vaccination programmes working? Scientists seek first clues.新冠疫苗接种计划是否有效？科学家们寻找初步线索。
Nature. 2021 Jan;589(7843):504-505. doi: 10.1038/d41586-021-00140-w.
4
Attitudes of healthcare workers towards COVID-19 vaccination: a survey in France and French-speaking parts of Belgium and Canada, 2020.医护人员对 COVID-19 疫苗接种的态度：2020 年在法国及比利时和加拿大法语区进行的一项调查。
Euro Surveill. 2021 Jan;26(3). doi: 10.2807/1560-7917.ES.2021.26.3.2002047.
5
Willingness to Receive COVID-19 Vaccination in Japan.日本民众接种新冠疫苗的意愿。
Vaccines (Basel). 2021 Jan 14;9(1):48. doi: 10.3390/vaccines9010048.
6
Maintaining Safety with SARS-CoV-2 Vaccines.通过新冠病毒疫苗维持安全性。
N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30.
7
COVID-19 vaccine hesitancy among medical students.医学生对 COVID-19 疫苗的犹豫。
J Public Health (Oxf). 2021 Sep 22;43(3):445-449. doi: 10.1093/pubmed/fdaa230.
8
9
Attitudes towards influenza vaccine and a potential COVID-19 vaccine in Italy and differences across occupational groups, September 2020.2020 年 9 月，意大利民众对流感疫苗和潜在 COVID-19 疫苗的态度，以及不同职业群体之间的差异。
Med Lav. 2020 Nov 17;111(6):445-448. doi: 10.23749/mdl.v111i6.10813.
10
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
Zotero 插件